EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY 4.0

Adherence to Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration

Frank G Holz, Focke Ziemssen, Ulrike Bauer-Steinhusen, Joachim Wachtlin, Markus Schürks, Katrin Lorenz, Paula Scholz, Tobias Machewitz, Christine Rech, Ines Lanzl, Albrecht Lommatzsch, Robert P Finger und 1 weitere

Ophthalmology Retina · 2026-03 · 10 (3) · 241-249

DOI: 10.1016/j.oret.2025.09.004 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Ophthalmology Retina, 2026-03. Verfasst von Frank G Holz und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University of Bonn, Bonn, Germany. Electronic address: Frank.Holz@ukbonn.de. Hauptthemen laut MEDLINE: Receptors, Vascular Endothelial Growth Factor, Recombinant Fusion Proteins, Visual Acuity, Wet Macular Degeneration. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bayer Vital GmbH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Vascular Endothelial Growth FactorRecombinant Fusion ProteinsVisual AcuityWet Macular DegenerationHumansFemaleIntravitreal InjectionsAgedMaleProspective StudiesFollow-Up StudiesAngiogenesis InhibitorsAged, 80 and overTomography, Optical CoherenceTreatment OutcomeTime FactorsVascular Endothelial Growth Factor AMiddle AgedDose-Response Relationship, Drug

Stichwörter der Autor:innen

AdherenceAnti-VEGFClinical settingNeovascular age-related macular degenerationRisk factor

Substanzen

afliberceptReceptors, Vascular Endothelial Growth FactorRecombinant Fusion ProteinsAngiogenesis InhibitorsVascular Endothelial Growth Factor A

Autor:innen und Institutionen

  • Department of Ophthalmology, University of Bonn, Bonn, Germany. Electronic address: Frank.Holz@ukbonn.de.
  • Department of Ophthalmology, University of Leipzig, Leipzig, Germany; Center for Ophthalmology, Eberhard Karl University Tuebingen, Tuebingen, Germany.
  • Bayer Vital GmbH, Leverkusen, Germany.
  • Alexianer Sankt-Gertrauden Krankenhaus, Berlin, Germany; MHB, Medizinische Hochschule Brandenburg, Neuruppin, Germany.
  • Department of Ophthalmology, University Medical Center, Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Bayer AG, Berlin, Germany.

Förderung

  • Bayer Vital GmbH

Zitieren

APA

Holz, F. G., Ziemssen, F., Bauer-Steinhusen, U., Wachtlin, J., Schürks, M., Lorenz, K., Scholz, P., Machewitz, T., Rech, C., Lanzl, I., Lommatzsch, A., Finger, R. P., & ANDROMEDA Study Group (2026). Adherence to Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration. Ophthalmology Retina, 10(3), 241-249. https://doi.org/10.1016/j.oret.2025.09.004

Vancouver

Holz FG, Ziemssen F, Bauer-Steinhusen U, Wachtlin J, Schürks M, Lorenz K, et al. Adherence to Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration. Ophthalmology Retina. 2026;10(3):241-249. doi:10.1016/j.oret.2025.09.004

BibTeX
@article{Holz2026,
  author = {Holz, Frank G and Ziemssen, Focke and Bauer-Steinhusen, Ulrike and Wachtlin, Joachim and Schürks, Markus and Lorenz, Katrin and Scholz, Paula and Machewitz, Tobias and Rech, Christine and Lanzl, Ines and Lommatzsch, Albrecht and Finger, Robert P and ANDROMEDA Study Group, ANDROMEDA Study Group},
  title = {Adherence to Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration},
  journal = {Ophthalmology Retina},
  year = {2026},
  volume = {10},
  number = {3},
  pages = {241--249},
  doi = {10.1016/j.oret.2025.09.004}
}
Kostenlos starten →